Cargando…
A monoclonal antibody against the Wnt signaling inhibitor dickkopf-1 inhibits osteosarcoma metastasis in a preclinical model
The outcome of patients with metastatic osteosarcoma has not improved since the introduction of chemotherapy in the 1970s. Development of therapies targeting the metastatic cascade is a tremendous unmet medical need. The Wnt signaling pathway has been the focus of intense investigation in osteosarco...
Autores principales: | Goldstein, Seth D., Trucco, Matteo, Guzman, Wendy Bautista, Hayashi, Masanori, Loeb, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008272/ https://www.ncbi.nlm.nih.gov/pubmed/27049730 http://dx.doi.org/10.18632/oncotarget.8522 |
Ejemplares similares
-
Inhibition of porcupine prolongs metastasis free survival in a mouse xenograft model of Ewing sarcoma
por: Hayashi, Masanori, et al.
Publicado: (2017) -
Effects of a novel Nodal-targeting monoclonal antibody in melanoma
por: Strizzi, Luigi, et al.
Publicado: (2015) -
Immunotherapy of SARS based on combinations of neutralizing human monoclonal antibodies
por: Du, Lanying, et al.
Publicado: (2010) -
RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models
por: Wong, Oi Kwan, et al.
Publicado: (2018) -
Comparison of SARS-CoV-2 RT-PCR on a high-throughput molecular diagnostic platform and the cobas SARS-CoV-2 test for the diagnostic of COVID-19 on various clinical samples
por: Opota, Onya, et al.
Publicado: (2020)